SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-277423
Filing Date
2022-11-04
Accepted
2022-11-04 08:00:35
Documents
13
Period of Report
2022-11-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d389567d8k.htm   iXBRL 8-K 29966
2 EX-99.1 d389567dex991.htm EX-99.1 6682
  Complete submission text file 0001193125-22-277423.txt   162113

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20221103.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20221103_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20221103_pre.xml EX-101.PRE 11259
7 EXTRACTED XBRL INSTANCE DOCUMENT d389567d8k_htm.xml XML 3349
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 221360220
SIC: 2834 Pharmaceutical Preparations